Price $96.14 |
Market Cap
2.72B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.77
|
P/S
2.53
|
Dividend %
0.90%
|
|
P/CF
709.4
|
P/FCF
80.5
|
Op. Cash Flow
78.7K
|
FCF
1.1
|
|
Op. Margin
0.20%
|
Net Margin
-7.70%
|
ROE
-11.20%
|
ROI
6.70%
|
|
ROA
-4.20%
|
EPS Growth
-230.10%
|
Current Ratio
2.3
|
Debt/Equity
85.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Avalo Therapeutics Inc (AVTX) | $4.03 | - | - | 47.6M | Strong Buy |
| Ligand Pharmaceuticals Inc (LGND) | $76.61 | - | - | 1.14B | Strong Buy |
| Community Health Systems Inc (CYH) | $4.74 | - | - | 576.6M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.44 | - | - | 14.9M | Strong Buy |
| Aveanna Healthcare Holdings In (AVAH) | $1.31 | - | - | 125.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
